The realistic upside is strong but bounded. Lemonade has a credible path to materially higher revenue because auto, multi-product attachment,
embedded distribution, and claims automation can scale faster than headcount. But this is still insurance, not software: price shopping is easy, capital and reinsurance matter, and regulators can slow model advantages. That supports a solid
premium multiple in 2031, not a pure-AI moonshot multiple.